Document Detail


Patient compliance and angiotensin converting enzyme inhibitors in hypertension.
MedLine Citation:
PMID:  1691414     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Patient compliance is crucial to successful medical treatment. Many factors contribute to compliance, including age, sex, other sociodemographic factors, finances, intelligence, complexity of therapeutic regimen, and patient-physician rapport. Compliance is especially critical in medical conditions requiring prolonged therapy, such as hypertension. Historically, compliance among hypertensive patients has been alarmingly poor, with a 50% drop-off after 1 year and fewer than 20% still in therapy after 5 years. The use of enalapril, the long-acting angiotensin converting enzyme (ACE) inhibitor that allows for a once-daily regimen, has improved treatment success and compliance. This probably is due to the efficacy of the drug, coupled with a low incidence of side effects.
Authors:
L I Juncos
Related Documents :
24490444 - Future drugs for the treatment of dry cough.
2262714 - Pattern of drug compliance in leprosy patients attending urban centres--a longitudinal ...
10250814 - Educational support groups of patients with ankylosing spondylitis: a preliminary report.
16117984 - Medication adherence before an increase in antihypertensive therapy: a cohort study usi...
9494984 - Anesthesia on the rheumatoid patient.
14676474 - Sex-related hearing impairment in wolfram syndrome patients identified by inactivating ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  15 Suppl 3     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1990  
Date Detail:
Created Date:  1990-05-11     Completed Date:  1990-05-11     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  S22-5     Citation Subset:  IM    
Affiliation:
University of Cordoba School of Medicine, Argentina.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Enalapril / therapeutic use*
Female
Humans
Hypertension / drug therapy*
Male
Middle Aged
Patient Compliance
Chemical
Reg. No./Substance:
75847-73-3/Enalapril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  JNC-IV and the evolution of stepped care to individualized treatment of hypertension.
Next Document:  Enalapril: benefit-to-risk ratio in hypertensive patients.